Answer
Before prescribing Symkevi to a patient whose CFTR genotype is unknown, an accurate and validated genotyping method using a genotyping assay should confirm the presence of an indicated mutation.
Sources for this answer
- Symkevi 100 mg/150 mg tablets PLGB 22352/0003Vertex Pharmaceuticals (Europe) Limited · emc · SmPC §4.2 Posology and method of administration · Version 14Document updated
Sources checked